The global cytotoxic drugs market is estimated to grow at a CAGR of nearly 1.3% during the forecast period. The major factors contributing to the growth of the market include a significant rise in cancer incidences and increasing awareness regarding cancer diseases. As per the World Health Organization (WHO), in 2018, the cancer burden across the globe is anticipated to have increased to 18.1 million new incidences and 9.6 million mortalities. Globally, one in 5 men and one in 6 women develop cancer in their lifetime. Globally, 43.8 million patients were suffering from cancer in 2018.
Get Free Sample Copy @https://www.omrglobal.com/request-sample/cytotoxic-drugs-market
Due to the increasing cancer incidences, the public-private partnership across countries have been witnessed to raise public awareness regarding cancer. For instance, in May 2016, F. Hoffman L-Roche AG launched Run for Her, an awareness campaign for breast cancer, in partnership with the China Cancer Rehabilitation Society. The program aims to improve breast cancer awareness, testing, and treatment in China. The campaign successfully delivered crucial messages that women should get breast cancer screening on a regular basis, and the early diagnosis and standardized treatment enable to improve both the quality of life and disease outcome.
Browse for Full Report Description@https://www.omrglobal.com/industry-reports/cytotoxic-drugs-market
This initiative can support Chinese women to get access to better screening, diagnosis, and treatment, which in turn, will encourage the demand for cytotoxic drugs as these are used to destroy cancer cells. These drugs restrict the division of cells and thereby kills cancerous cells. As a result, it boosts the outcomes of radiotherapy or surgery, decreases metastases, and ease cancer symptoms. However, there is a decrease in the role of cytotoxic drugs in cancer therapies to some extent due to the development of other drug therapies. However, it is being significantly used in antineoplastic chemotherapy. The pipeline drugs are expected to offer an opportunity for market growth.
Market Segmentation
Global Cytotoxic Drugs Market by Drug Class
Alkylating
Antimetabolites
Antitumor Antibiotics
Plant Alkaloids
Others
Global Cytotoxic Drugs Market by Application
Lung Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Others
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles
AbbVie Inc.
Amgen Inc.
Bayer AG
Bristol Myers Squibb Co.
Cipla Ltd.
Daiichi Sankyo Company, Ltd.
Eli Lilly and Co.
F. Hoffman La-Roche AG
Fresenius SE & Co. KGaA
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Lonza Group Ltd.
Lupin Ltd.
Merck & Co., Inc.
Mylan N.V.
Novartis International AG
Pfizer Inc.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cytotoxic-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email:
[email protected]
Contact no: +91 780-304-0404